Virginia Governor’s Veto Of Marijuana Sales Bill Would Erase Millions In Revenue For Pre-K And Drug Treatment, State Report Shows

With Virginia Gov. Glenn Youngkin (R) widely expected to veto a lawmaker-passed plan to legalize retail marijuana sales in the commonwealth, a new fiscal impact statement makes clear that rejecting the proposal would mean missing out on tens of millions of dollars in annual state revenue—including for pre-kindergarten programs, community reinvestment and substance use treatment.

Annual government revenue would begin at an estimated $7.3 million in fiscal year 2026, according to the Department of Taxation, rising steadily as the regulated system got off the ground. By fiscal year 2031, the figure is projected to climb to an annual $87.84 million.

All told, by the end of fiscal 2031, retail cannabis is expected to bring Virginia nearly $300 million in total revenue.

The income would come from an 8 percent excise tax on marijuana sales and a 1.125 percent sales tax imposed under the legislation, from Sen. Aaron Rouse (D) and Rep. Paul Krizek (D).

The numbers were published on Friday in a report from the state Department of Planning and Budget.

The top-level revenue projection does not include separate, local taxes of up to 2.5 percent. Depending on how broadly municipalities implement those taxes, they could bring in up to $2 million statewide in fiscal 2026, rising to an estimated $24.09 million by fiscal 2031.

The bulk of the state money would go to community reinvestment. The Cannabis Equity Reinvestment Fund would receive an estimated $1.92 million in fiscal 2026, which would rise to $46.26 million in fiscal 2031.

Money would also go to preventing and treating substance use disorders. That would be about $1.92 million in fiscal 2026, rising to $19.27 in fiscal 2031.

Revenue would also fund pre-kindergarten programs (beginning at $2.56 million initially and rising to $7.72 million annually in fiscal 2031), public health programs ($320,000 initially and rising to $3.85 million in fiscal 2031) and other initiatives.

In terms of how the revenue is divided, that would change over time. Until fiscal 2027, 40 percent would fund pre-K, 30 percent would go to the reinvestment fund, 25 percent would go toward substance use disorders and 5 percent would fund public health programs. After that, 10 percent would go to pre-K, 60 percent to community reinvestment, 25 percent to substance use disorders and 5 percent to public health.

As for costs, preparing for and administering a regulated retail sales program would cost several million dollars per year—about $9.37 million total in fiscal 2026 and an estimated $9.26 annually after that.

Licensing fees for marijuana businesses would pay the bulk of administrative costs at the Cannabis Control Authority (CCA), which would regulate the adult-use retail system. During its first year, however, some funds would also need to come from the state general fund.

New expenses at CCA would include 73 more staff members as well as technology and equipment, vehicles and travel.

The Department of Taxation, meanwhile, would incur estimated costs of $468,950 during the first fiscal year of operation in order to update forms and internal systems.

State Police, meanwhile, would incur just over $200,000 annually to hire two additional staff members to conduct fingerprinting and background checks.

Despite the fiscal impact report indicating that legalizing retail sales could bring Virginia hundreds of millions of dollars in tax revenue over the next several years, the state’s governor is widely expected to veto the lawmaker-passed bills.

Youngkin vetoed a nearly identical proposal last legislative session, and his office has said he’s inclined to do the same this year.

Keep reading

Pennsylvania Is ‘Losing Out’ To Neighboring States By Keeping Marijuana Illegal, Governor Says

As Pennsylvania lawmakers once again consider proposals to legalize marijuana, the governor is emphasizing that the state is “losing out” to others that have already enacted the reform, while maintaining a policy that’s enriched the illicit market.

During a wide-ranging video that was released on Monday, Gov. Josh Shapiro (D) was asked about his call to legalization cannabis for adult use, which he included in his latest budget request that’s been discussed at multiple committee hearings over recent weeks.

“I think it’s an issue of freedom and liberty. I mean, if folks want to smoke, they should be able to do so in a safe and legal way,” he said. “We should shut down the black market—and, by the way, every state around us is doing it. Pennsylvanians are driving to those other states and paying taxes in those other states.”

“It’s time we get some of that revenue here,” Shapiro said.

Keep reading

Governor Youngkin’s expected cannabis veto: A $3.5 billion gift to Mexican cartels and Chinese gangs

As Governor Glenn Youngkin once again faces a bipartisan bill that would establish a regulated cannabis distribution platform in Virginia, it is widely anticipated that he will act against the public’s interest just as he did in March 2024. In the twelve months since his last veto, the only certainty is that Mexican cartels and Chinese gangs have benefited from $3.5 billion in untaxed, unregulated cannabis sales while the proliferation of hemp-based THC products has skyrocketed. We anticipate that Youngkin will once again roll out his prohibitionist arguments but will fail to point to any tangible decrease in illegal cannabis sales the over the last 12-month— further proving that gifting Mexican cartels and Chinese drug dealers $3.5 billion and allowing the proliferation of illegal stores from Arlington to the Tennessee state line has only benefited organized crime at the expense of Virginians.

Youngkin’s argument hinges on a fundamental contradiction. He acknowledges that Virginia’s current system is “pervasive and dangerous,” yet refuses to implement the one policy proven to reduce illegal markets — regulation. Instead, he clings to outdated scare tactics, misrepresenting data from other states while ignoring the realities of his own.

Prohibitionists once used the same flawed logic to keep whiskey illegal, relying on bootleggers to supply demand while enriching organized crime. The parallels to cannabis today are undeniable. By refusing to regulate cannabis, Youngkin is ensuring that the only suppliers are Mexican cartels and Chinese gangs, just as Prohibition once empowered the Mafia. This policy failure is not just historical irony — it is a $3.5 billion mistake.

Keep reading

Idaho Lawmakers Approve Measure To Block Voters From Being Able To Legalize Marijuana

The Idaho House passed a resolution on Wednesday seeking voter approval to amend the state constitution and give the Legislature exclusive authority to regulate marijuana.

House Joint Resolution 4 aims to eliminate voters’ ability to legalize marijuana through a ballot initiative. As a resolution, the legislation does not hold the force of law. Instead, it would place a question on Idahoans’ ballot about whether to amend Idaho’s Constitution to allow only the Legislature to have a say in legalizing “psychoactive substances.” A majority of voters would need to vote yes in order for the constitution to be amended.

Currently, a “Decriminalize Cannabis Now” ballot initiative is in the signature gathering process, according to VoteIdaho.gov. If it qualifies, and if the Senate approves House Joint Resolution 4, then both questions would appear on the 2026 ballot, sponsor Rep. Bruce Skaug, R-Nampa said.

Skaug said the resolution comes from a place of concern for the “virtue and sobriety” of Idahoans.

“It’s time for Idahoans to proactively decide the state’s fate relative to marijuana, psychoactive substances and narcotics,” Skaug said. “I’m asking that we let our state go on the offense.”

Keep reading

Marijuana Consumers Are Under Attack In Multiple States, And It’s Time To Fight Back

Seventy percent of Americans, including majorities of Democratic and Republican voters, say that marijuana should be legal for adults. Yet this legislative session, lawmakers from both parties are placing cannabis consumers in their crosshairs.

In Republican-led states like Montana, Nebraska, Ohio and South Dakota, lawmakers are seeking to either repeal or significantly roll back voter-approved legalization laws. In Democrat-led states like California, Maryland, Michigan and New Jersey, lawmakers are seeking to undermine existing legalization markets by drastically hiking marijuana-related taxes.

In all cases, elected officials are treating cannabis consumers as targets, not constituents.

These concerted attacks on state-legal marijuana markets are an explicit reminder that the war on cannabis and its consumers remains ongoing and, in some cases, is escalating. Our opponents haven’t gone away; in many cases they’ve simply regrouped and tweaked their strategies–such as by advocating for arbitrary THC potency caps or calling for new criminal penalties for consumers who don’t obtain their cannabis from state-licensed dispensaries.

Those who oppose legalization have also become bolder and more cynical in their tactics. No longer convinced that they can win the hearts and minds of voters, they are now frequently seeking to remove them from the equation altogether.

Earlier this year, Republican lawmakers in South Dakota sought to repeal the state’s voter-initiated medical cannabis access law, despite 70 percent of voters having approved it. The effort failed, but only by a single vote.

In Nebraska, lawmakers are also considering legislation to roll back that state’s voter-approved medical marijuana law and the state’s Republican attorney general has urged lawmakers to ignore the election results altogether.

In Ohio, GOP lawmakers in the Senate recently approved legislation to rescind many of the legalization provisions approved by voters in 2023. Changes advanced by lawmakers include limiting home-cultivation rights, imposing THC potency limits and creating new crimes for adults who share cannabis with one another or who purchase cannabis products from out of state.

In Texas, Republican Attorney General Ken Paxton has sued several cities, including Dallas, for implementing voter-approved ordinances decriminalizing marijuana possession. As a result, local lawmakers in various municipalities–including Lockhart and Bastrop–are ignoring voters’ decisions to rethink their marijuana policies rather than face potential litigation.

Keep reading

New Hampshire Lawmakers Move Forward With Plan To Legalize Simple Possession Of Marijuana

Committees in New Hampshire on Wednesday took action on a handful of marijuana bills, advancing a plan that would legalize the simple possession by adults as well as a proposal to double existing possession limits for medical cannabis patients and caregivers. They put a pause, however, on broader legislation to legalize and regulate a commercial recreational marijuana market.

At a hearing, the House Criminal Justice and Public Safety Committee gave its approval to two different bills. One—HB 198, from Rep. Jared Sullivan (D)—takes a simple, unregulated approach to marijuana legalization.

If approved, the measure would allow adults 21 and older to possess up to two ounces of marijuana flower, 10 grams of concentrate and up to 2,000 milligrams of THC in other cannabis products.

Retail sales of marijuana products, along with home cultivation, would remain illegal under the plan. Consuming marijuana on public land would also be prohibited.

Another bill—HB 190, from Rep. Heath Howard (D)—would increase the possession limit of medical marijuana by patients and caregivers, raising it to four ounces from the current two. Existing 10-day patient purchase limits would also increase from two ounces up to four.

Members of the committee voted 9–7 in favor of HB 198 and 14–0 to advance HB 190.

“We as a body have passed bills legalizing cannabis again and again,” Rep. Alissandra Murray (D), who made the motion to advance HB 198, said before Wednesday’s vote. “The people of New Hampshire have made it clear that they would like us to legalize cannabis.”

Keep reading

Colombian President Calls On Lawmakers To Legalize Marijuana To Combat Cartel Violence In The Illicit Market

The president of Colombia is calling on lawmakers to legalize marijuana in the country, arguing that prohibition “only brings violence” from cartels in the illicit market. And he’s also pushing other nations to legalize coca leaves for “for purposes other than cocaine.”

On Sunday, President Gustavo Petro warned in a social media post of the “multinationalization of the cocaine mafias,” claiming that there are more cartels today than before high-profile trafficker Pablo Escobar was caught and imprisoned.

“The empowerment of mafia organizations shows the failure of prohibition and the absence of alternative measures to simple prohibition,” the president said, according to a translation.

“My government will maintain full cooperation with all governments in the matter of confiscating cocaine,” he added. “And it has focused and will focus its action on large shipments and on high-ranking cocaine and money laundering bosses worldwide.”

Petro then said he’s asking the Colombian Congress to “legalize marijuana and remove violence from this crop.”

“The prohibition of marijuana in Colombia only brings violence,” he said.

Keep reading

Major Coalition Of Marijuana Groups Announces Week-Long Push In DC For Legalization And Clemency Under Trump Admin

Marijuana advocacy groups and industry stakeholders will be staging another demonstration in Washington, D.C. this spring to show support for federal legalization at a time of significant uncertainty about what might be achievable under the GOP-controlled Congress and White House.

Led by the Last Prisoner Project (LPP), the Cannabis Unity Week of Action will take place from April 28-May 1, bringing together a diverse coalition to “unite advocates, impacted individuals, and industry leaders to pressure Congress and the Trump administration to fully legalize cannabis and implement retroactive relief measures for those affected by prohibition-era policies.”

The week-long event will involve educational outreach, press conferences featuring congressional allies in the reform movement and “an action outside the White House to honor those still incarcerated for cannabis and demand their freedom via presidential clemency.”

Keep reading

Dozens Of New Jersey Marijuana Businesses Push To Legalize Home Cultivation, Despite Resistance From Governor And Legislative Leaders

Dozens of New Jersey small marijuana businesses and advocacy groups are calling on the state legislature to allow adults to cultivate their own cannabis at home—seemingly contradicting repeated claims from the governor and legislative leaders that the reform could undermine the evolving legal marketplace.

And as Gov. Phil Murphy (D) is set to term out at the end of the year, activists are drawing attention where his potential successors stand on the issue as well.

The more than 50 businesses and advocates, which formed a collective known as the New Jersey Home Grow Coalition last year, signed an open letter to Senate President Nicholas Scutari (D), rejecting the idea that the market needs more time to mature before people can be permitted to grow their own plants for personal use.

Unlike most other states that have enacted cannabis legalization, New Jersey continues to prohibit home cultivation for adults or medical marijuana patients.

“Even with our growing industry there’s no hope of access to the clean, consistent, strain-specific medicine that I need for my epilepsy,” Andrea Raible, co-founder of the NJ Homegrow Coalition, said in a press release. “Politicians are concerned with adult use profits while we are concerned with life threatening health conditions and facing prison for plants.”

In the open letter to Scutari, who has broadly championed cannabis reform but has recently resisted calls for home cultivation, the members of the New Jersey marijuana community said “discussions on home cultivation in New Jersey have stalled, attributed to allowing the industry ‘time to mature.’”

“As licensed cannabis operators, stakeholders in the industry, and relevant organizations, we respectfully disagree with this statement. The legalization of medical home cultivation will not negatively impact the legal state cannabis industry,” they said. “We firmly support the immediate legalization of medical home cultivation for patients and caregivers. We also endorse additional legislation to be introduced that allows for the legalization of personal use home cultivation safely and equitably.”

The advocates and stakeholders are voicing support for an amendment to expand a pair of bills seeking to provide for medical cannabis home cultivation, making it so the plant limit would be replaced with an allowance to “allow up to 100 square feet of mature cannabis plant grow canopy area.”

“This would allow patients and caretakers to have the ability to properly pheno-hunt and cultivate an amount that meets individual needs,” they said. “Additionally, this change would mitigate the potential for exploiting the law through the cultivation of massive cannabis plants.”

Keep reading

Doctors Supporting Marijuana Rescheduling File Lawsuit Calling For DEA Witness Selection Redo Over Alleged Unlawful Conspiracy With Reform Opponents

A non-profit organization of pro-marijuana reform doctors has filed a brief in a federal appeals court arguing that new evidence has surfaced demonstrating that the Drug Enforcement Administration (DEA) carried out an “arbitrary and capricious review” of witnesses for hearings on the ongoing cannabis rescheduling process that should now be redone.

The group is alleging that there’s “substantial evidence” of procedural violations committed by DEA leadership during the witness selection process—including previously unreported unlawful ex parte communications with certain parties, most of whom oppose the rescheduling proposal.

The suit from Doctors for Drug Policy Reform (D4DPR)—filed with the U.S. Court of Appeals for the District of Columbia Circuit on Monday—comes amid an indefinite delay of the DEA administrative hearings on the Biden administration-initiated proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).

At issue in the legal challenge is the fact that then-DEA Administrator Anne Milgram selected just 25 of more than 160 applicants that sought to provide input on the rescheduling proposal.

According to attorneys represented by D4DPR, which was among the groups denied designated participant status for the hearings, there’s substantial evidence that DEA’s ex parte communications were “motivated by the impermissible goal of creating an evidentiary record that would allow it to reject the proposed rule to reschedule marijuana.”

“The Agency gave no reasons for selecting only 25 participants or why it selected particular applicants,” the lawsuit says. “The Agency’s failure to explain the reasons for its selections warrants vacatur and remand with instructions to redo the selections.”

Keep reading